About Ikaria Australia
Ikaria Australia is a company based in Kew (Australia) founded in 2010 was acquired by Mallinckrodt Pharmaceuticals in April 2015.. Ikaria Australia offers products and services including INOmax Cylinders, INOmax Consumables, THERAKOS Kits, and UVADEX. Ikaria Australia operates in a competitive market with competitors including MannKind Corp, Impel NeuroPharma, Alexza, OptiNose and Qnovia, among others.
- Headquarter Kew, Australia
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Ikaria Aust Pty Ltd
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
- Investors
-
Employee Count
Employee Count
-
Acquired by
Mallinckrodt Pharmaceuticals
(Apr 16, 2015)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Ikaria Australia
Ikaria Australia offers a comprehensive portfolio of products and services, including INOmax Cylinders, INOmax Consumables, THERAKOS Kits, and UVADEX. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Inhalation therapy system for respiratory support in healthcare.
Components for INOmax systems to aid patient treatment.
Photopheresis kits for treating immune disorders.
Drug used in photopheresis procedures for medical applications.
Funding Insights of Ikaria Australia
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Ikaria Australia
Ikaria Australia has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Mallinckrodt Pharmaceuticals. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Specialty pharmaceutical products and diagnostic imaging agents are manufactured.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Ikaria Australia
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Ikaria Australia
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Ikaria Australia Comparisons
Competitors of Ikaria Australia
Ikaria Australia operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MannKind Corp, Impel NeuroPharma, Alexza, OptiNose and Qnovia, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of small-molecule drugs
|
|
| domain | founded_year | HQ Location |
Intranasal delivery technology for CNS diseases is developed.
|
|
| domain | founded_year | HQ Location |
Developer of products for the treatment of acute and intermittent conditions
|
|
| domain | founded_year | HQ Location |
Developer of smart devices for nasal drug delivery
|
|
| domain | founded_year | HQ Location |
Inhaled drug delivery devices are developed for pharmaceuticals.
|
|
| domain | founded_year | HQ Location |
Therapeutics for cardiopulmonary diseases are developed using inhaled therapies.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Ikaria Australia
When was Ikaria Australia founded?
Ikaria Australia was founded in 2010.
Where is Ikaria Australia located?
Ikaria Australia is headquartered in Kew, Australia. It is registered at Kew, Victoria, Australia.
What does Ikaria Australia do?
Ikaria is a part of Mallinckrodt Pharmaceuticals. They are developing a drug delivery system for treating congestive heart failure and acute myocardial infarction. Their lead candidate INOMAX which is a nitric oxide inhalation, for treating bronchopulmonary dysplasia (BPD) in premature infants, pulmonary arterial hypertension (PAH), and chronic obstructive pulmonary disease (COPD).
Who are the top competitors of Ikaria Australia?
Ikaria Australia's top competitors include MannKind Corp, OptiNose and Impel NeuroPharma.
What products or services does Ikaria Australia offer?
Ikaria Australia offers INOmax Cylinders, INOmax Consumables, THERAKOS Kits, and UVADEX.
Who are Ikaria Australia's investors?
Ikaria Australia has 1 investor. Key investors include Mallinckrodt Pharmaceuticals.